{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "PDGFRA",
                "DNA Alteration": "c.2525A>T",
                "GeneMutation": "p.K385L Frameshift-GOF",
                "VariantAlleleFraction": "20.33%"
            },
            {
                "Gene": "DPYD",
                "DNA Alteration": "c.1236G>A",
                "GeneMutation": "p.I560S Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "8.29%"
            },
            {
                "Gene": "ALK",
                "DNA Alteration": "c.3733T>C",
                "GeneMutation": "p.T1087I Nonsense-GOF",
                "VariantAlleleFraction": "12.7%"
            },
            {
                "Gene": "MTOR",
                "DNA Alteration": "c.5664C>G",
                "GeneMutation": "p.G1954R Spliceregionvariant-GOF",
                "VariantAlleleFraction": "9.9%"
            },
            {
                "Gene": "TP53",
                "DNA Alteration": "c.523C>T",
                "GeneMutation": "p.R273S Spliceregionvariant-GOF",
                "VariantAlleleFraction": "8.58%"
            },
            {
                "Gene": "PTCH1",
                "DNA Alteration": "c.3583A>T",
                "GeneMutation": "p.T1195S Nonsense-GOF",
                "VariantAlleleFraction": "1.17%"
            },
            {
                "Gene": "AKT1",
                "DNA Alteration": "c.49G>A",
                "GeneMutation": "p.E17K Frameshift-LOF",
                "VariantAlleleFraction": "5.53%"
            },
            {
                "Gene": "CCND3",
                "DNA Alteration": "c.766_776del11",
                "GeneMutation": "p.R256fs*64 Spliceregionvariant-GOF",
                "VariantAlleleFraction": "6.18%"
            },
            {
                "Gene": "JAK3",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.L857P Frameshift-LOF",
                "VariantAlleleFraction": "4.71%"
            },
            {
                "Gene": "ABL1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A34V Spliceregionvariant-GOF",
                "VariantAlleleFraction": "1.05%"
            },
            {
                "Gene": "CTNNB1",
                "DNA Alteration": "c.110C>G",
                "GeneMutation": "p.D32Y Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.33%"
            },
            {
                "Gene": "NTRK1",
                "DNA Alteration": "c.1792C>T",
                "GeneMutation": "p.H598T Stopgain-LOF",
                "VariantAlleleFraction": "5.84%"
            }
        ],
        "Germline": []
    }
}